Long‐term results of concurrent chemoradiotherapy using cisplatin and vinorelbine for stage <scp>III</scp> non‐small‐cell lung cancer
Hidehito Horinouchi(Tokyo National Hospital), Tomohide Tamura(St. Luke's International Hospital), Kiyoshi Mori(Columbia University), Minako Sumi(Tokyo Metropolitan Geriatric Hospital), Kazumasa Noda, Ikuo Sekine(University of Tsukuba), Kōichi Goto(National Cancer Center Hospital East)
Cited by 38
Related Papers
Metabolic gene polymorphism frequencies in control populations.
|PubMed|2001|847
Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|835
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies
|Nature Immunology|2020|810
Association between Increases in Urinary Neutrophil Gelatinase–associated Lipocalin and Acute Renal Dysfunction after Adult Cardiac Surgery
|Anesthesiology|2006|570
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials
|The Lancet Oncology|2019|537